(Q45862807)

English

IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response

scientific article published in October 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

colon carcinoma

1 reference

based on heuristic

inferred from title

author name string

Adris S

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

Klein S

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

Jasnis M

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

Chuluyan E

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

Ledda M

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

Bravo A

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

Carbone C

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

Chernajovsky Y

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

Podhajcer O

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

10

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

1705-1712

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

Experimental and clinical studies of cytokine gene-modified tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Interleukin 10: a novel stimulatory factor for mast cells and their progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Two types of mouse helper T-cell clone Implications for immune regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

The role of TH1 and TH2 cells in a rodent malaria infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Lymphocyte responses and cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Interleukin-10 Inhibits Tumor Metastasis, Downregulates MHC Class I, and Enhances NK Lysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Mechanisms of cytokine-mediated localized immunoprotection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Synthesis of preparative amounts of biologically active interleukin-6 using a continuous-flow cell-free translation system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

21 January 2018

Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

7 January 2021

based on heuristic

inferred from DOI database lookup

The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301012

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3301012

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/10516719

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45862807&oldid=2207394087"